OTCMKTS:SHWZ

Medicine Man Technologies Stock Forecast, Price & News

$2.34
+0.06 (+2.64 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.18
$2.34
50-Day Range
$2.02
$2.82
52-Week Range
$1.05
$3.25
Volume40,870 shs
Average Volume172,603 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SHWZ News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicine Man Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Consulting Services
Sub-IndustryN/A
Current SymbolOTCMKTS:SHWZ
CUSIPN/A
CIKN/A
Phone(303) 371-0387
Employees244
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date5/13/2021 (Estimated)
OptionableNot Optionable

Headlines

See More Headlines
Medicine Man Technologies logo

About Medicine Man Technologies

Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. The company provides cannabis products for various edible companies; and vape cartridges and syringes. As of March 17, 2021, it owned and operated 17 dispensaries in Colorado under the brand name Star Buds. In addition, the company provides consulting services for cannabis businesses; and Three A Light, cannabis grower's guide book. Further, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is based in Denver, Colorado.

MarketRank

Overall MarketRank

1.70 out of 5 stars

Industrials Sector

8th out of 386 stocks

Consulting Services Industry

1st out of 9 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Medicine Man Technologies (OTCMKTS:SHWZ) Frequently Asked Questions

Is Medicine Man Technologies a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medicine Man Technologies in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Medicine Man Technologies stock.
View analyst ratings for Medicine Man Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than Medicine Man Technologies?

Wall Street analysts have given Medicine Man Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medicine Man Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Medicine Man Technologies' next earnings date?

Medicine Man Technologies is scheduled to release its next quarterly earnings announcement on Thursday, May 13th 2021.
View our earnings forecast for Medicine Man Technologies
.

What guidance has Medicine Man Technologies issued on next quarter's earnings?

Medicine Man Technologies updated its FY 2021 earnings guidance on Tuesday, April, 27th. The company provided EPS guidance of - for the period. The company issued revenue guidance of $105 million-$125 million, compared to the consensus revenue estimate of $100.70 million.

What price target have analysts set for SHWZ?

1 Wall Street analysts have issued 1-year price targets for Medicine Man Technologies' shares. Their forecasts range from $4.00 to $4.00. On average, they expect Medicine Man Technologies' stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 71.3% from the stock's current price.
View analysts' price targets for Medicine Man Technologies
or view top-rated stocks among Wall Street analysts.

Who are Medicine Man Technologies' key executives?

Medicine Man Technologies' management team includes the following people:
  • Mr. Justin C. Dye, Exec. Chairman & CEO (Age 48, Pay $231.28k)
  • Ms. Nancy Huber, Chief Financial Officer (Age 62)
  • Dr. Nirup N. Krishnamurthy, Chief Operating Officer (Age 58)
  • Mr. Lee A. Dayton, Chief Admin. Officer
  • Mr. Daniel Pabon, Gen. Counsel, Chief Gov. Affairs Officer & Corp. Sec. (Age 43)
  • Raquel Fuentes, Sr. Director of Corp. Communications
  • Mr. Shane Sampson, Chief Marketing & Merchandising Officer (Age 56)
  • Mr. Todd Williams, Chief Strategy Officer

Who are some of Medicine Man Technologies' key competitors?

What other stocks do shareholders of Medicine Man Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Charlotte's Web (CWBHF), GrowGeneration (GRWG), Harvest Health & Recreation (HRVSF), Trulieve Cannabis (TCNNF), (CGC), Curaleaf (CURLF), ETFMG Alternative Harvest ETF (MJ), OrganiGram (OGI), Village Farms International (VFF) and Cresco Labs (CRLBF).

What is Medicine Man Technologies' stock symbol?

Medicine Man Technologies trades on the OTCMKTS under the ticker symbol "SHWZ."

How do I buy shares of Medicine Man Technologies?

Shares of SHWZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medicine Man Technologies' stock price today?

One share of SHWZ stock can currently be purchased for approximately $2.34.

How many employees does Medicine Man Technologies have?

Medicine Man Technologies employs 244 workers across the globe.

What is Medicine Man Technologies' official website?

The official website for Medicine Man Technologies is www.schwazze.com.

How can I contact Medicine Man Technologies?

The company can be reached via phone at (303) 371-0387.


This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.